These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7212479)

  • 1. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Stargel WW; Wagner GS; Shand DG
    Ann Intern Med; 1980 Nov; 93(5):701-4. PubMed ID: 7212479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of alpha-1-acid glycoprotein and its relation to myocardial enzymes after acute myocardial infarction.
    Giardina EG; Raby K; Freilich D; Vita J; Brem R; Louie M
    Am J Cardiol; 1985 Aug; 56(4):262-5. PubMed ID: 4025163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
    Nattel S; Gagne G; Pineau M
    Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of lidocaine after intramuscular injection and subsequent infusion in patients with acute myocardial infarction.
    Oltmanns D; Lübben C; Pentz R; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):582-4. PubMed ID: 7152740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral cimetidine on total and unbound serum lidocaine concentrations in patients with suspected myocardial infarction.
    Berk SI; Gal P; Bauman JL; Douglas JB; McCue JD; Powell JR
    Int J Cardiol; 1987 Jan; 14(1):91-4. PubMed ID: 3804509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of plasma alpha 1-glycoprotein acid in the binding of aminopyrine].
    el Allaf D; Demey-Ponsart E; Pirotte J; Chapelle JP; el Allaf M; Carlier J; Van Cauwenberge H
    Arch Int Physiol Biochim; 1986 Dec; 94(5):317-22. PubMed ID: 2440407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction.
    Koster RW; Dunning AJ
    N Engl J Med; 1985 Oct; 313(18):1105-10. PubMed ID: 3900727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.
    Barry M; Keeling PW; Weir D; Feely J
    Clin Pharmacol Ther; 1990 Mar; 47(3):366-70. PubMed ID: 2311337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
    Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
    Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related differences in the plasma protein binding of lignocaine and diazepam.
    Routledge PA; Stargel WW; Kitchell BB; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):245-50. PubMed ID: 7213526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam and lidocaine plasma protein binding in renal disease.
    Grossman SH; Davis D; Kitchell BB; Shand DG; Routledge PA
    Clin Pharmacol Ther; 1982 Mar; 31(3):350-7. PubMed ID: 7037263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Displacement of lidocaine from human plasma proteins by disopyramide.
    Bonde J; Jensen NM; Burgaard P; Angelo HR; Graudal N; Kampmann JP; Pedersen LE
    Pharmacol Toxicol; 1987 Feb; 60(2):151-5. PubMed ID: 3575249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-dependent lidocaine disposition in patients with acute myocardial infarction.
    Cusson J; Nattel S; Matthews C; Talajic M; Lawand S
    Clin Pharmacol Ther; 1985 Apr; 37(4):381-6. PubMed ID: 3978999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
    Prescott LF; Adjepon-Yamoah KK; Talbot RG
    Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.
    Wood M; Wood AJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):522-6. PubMed ID: 7471620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.